Alan Lerner, MD

University Hospitals Case Medical CenterCleveland, Ohio - 44106 (216-844-1800) |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS2
- SINCE2008

A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer s Disease
December 2008 - July 2011
Alzheimer Disease
Immune Globulin Intravenous (Human), 10% (Igiv, 10%)
Placebo Solution



